# US 2018/0021078 A1 · Preferential volume reduction of diseased segments of a heterogeneous lobe

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2018/0021078 A1
- Document ID: US20180021078A1
- Status: Published application
- Kind: A1
- Application number: 15/724,636
- Filed: 2017-10-04
- Published: 2018-01-25
- Earliest claimed: 2013-10-01
- Assignees: Uptake Medical Technology Inc.
- Applicants: Uptake Medical Technology Inc.
- Inventors: Robert Lawrence Barry; Erik Henne; Avina Gupta; Sourish Bandyopadhyay
- Web page: https://patentgrep.com/patent/US20180021078A1

## CPC

- A61B 18/04: by heating (by applying electromagnetic radiation A61B18/18)
- A61B 34/10: Computer-aided planning, simulation or modelling of surgical operations
- A61B 5/08: Measuring devices for evaluating the respiratory organs
- A61B 2018/00285: {Balloons}
- A61B 2018/00541: {Lung or bronchi}
- A61B 2018/048: {in gaseous form}
- A61B 2034/105: {Modelling of the patient, e.g. for ligaments or bones}
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)

## Abstract

Methods and apparatus for diagnosing and treating disorders of the lung are provided, which may include any number of features. In one embodiment, a method comprises obtaining diagnostic information relating to a patient's lungs, compiling a list of potential treatment plans for lung volume reduction in the first and second lungs, excluding treatment plans from the list of potential treatment plans that propose treatment of a lung segment that falls within a segment exclusion rule, and identifying at least one preferred treatment plan from the list of potential treatment plans that targets sufficiently diseased lung segments while also targeting a preferred combined volume of the first and second lungs.

## Claims

### Claim at position 1

1-33. (canceled)

### Claim 34

A treatment planning system for assisting a physician perform bronchoscopic lung volume reduction, the system including a processor operable to perform the following:
receive diagnostic information including information derived from images relating to a patient's first and second lungs;
compile a plurality of potential lung volume combinations for lung volume reduction in the first and second lungs wherein each potential lung volume combination includes at least one lung volume from the first lung and at least one lung volume from the second lung;
compute a plurality of diagnostic values for each lung volume of said potential lung volume combinations;
determine a segment exclusion rule operable to exclude one or more of the potential lung volume combinations based on comparing the diagnostic value from the computing step to a threshold value or range; and
exclude at least one of the potential lung volume combinations based on said segment exclusion rule.

### Claim 35 (depends on 34)

The system of claim 34 wherein the diagnostic values are selected from the group consisting of a tissue-to-air ratio, a heterogeneity index, an air volume, a mass, and a percentage of a lobe of each volume of the first and second lungs.

### Claim 36 (depends on 34)

The system of claim 34 wherein compiling comprises compiling a list of potential treatments that include a first treatment that targets a first segment of a first lobe of the first lung, and a second treatment that targets a second segment of a second lobe of the second lung.

### Claim 37 (depends on 36)

The system of claim 36 wherein the second treatment also targets a third segment of the second lobe of the second lung.

### Claim 38 (depends on 34)

The system of claim 34 wherein the segment exclusion rule requires that lung segment combinations including lung segments that have a heterogeneity index under 1.2 be excluded.

### Claim 39 (depends on 34)

The system of claim 34 wherein the segment exclusion rule requires that lung segment combinations including lung segments that have a mass less than 13 g be excluded.

### Claim 40 (depends on 34)

The system of claim 34 wherein the segment exclusion rule requires that lung segment combinations including segments having a tissue mass in grams plus air volume in milliliters greater than 1700 be excluded.

### Claim 41 (depends on 34)

The system of claim 34 wherein the segment exclusion rule requires that lung segment combinations that have a mass greater than 48 g be excluded.

### Claim 42 (depends on 34)

The system of claim 34 wherein the segment exclusion rule requires that lung segment combinations including treatment of the first lung that treats less than 30% of the volume of the first lung or more than 70% of the volume of the first lung be excluded.

### Claim 43 (depends on 34)

The system of claim 34 wherein the segment exclusion rule requires that lung segment combinations including treatment of the second lung that treats less than 40% of the volume of the second lobe or more than 80% of the volume of the second lobe be excluded.

### Claim 44 (depends on 34)

The system of claim 34 wherein the segment exclusion rule requires that lung segment combinations including a treatment of the first and second lungs resulting in less than 95% or greater than 130% of a combined percentage of volume of the first and second lungs be excluded.

### Claim 45 (depends on 34)

The system of claim 34 wherein the plurality of potential lung volume combinations includes at least one lung segment from the first lung and at least one lung segment from the second lung.

### Claim 46 (depends on 45)

The system of claim 45 wherein the at least one preferred lung segment combination requires treatment of segments with an insignificant difference in tissue-to-air ratios (TARs).

### Claim 47 (depends on 46)

The system of claim 46 wherein the insignificant difference comprises a difference of less than 2% between the TARs of the lung segments of the lung segment combination.

### Claim 48 (depends on 46)

The system of claim 46 wherein the at least one preferred segment combination requires treatment of lung segments that rank closest to 110% of a combined percentage of the first and second lungs to be treated.

### Claim 49 (depends on 45)

The system of claim 45, wherein the at least one preferred segment combination comprises applying lung volume reduction therapy to at least one lung segment in the first lung and at least one lung segment in the second lung.

### Claim 50 (depends on 49)

The system of claim 49 wherein the lung volume reduction therapy comprises delivering condensable vapor to the patient's lungs.

### Claim 51 (depends on 34)

The system of claim 34 further comprising identifying automatically on the processor or electronic controller, at least one preferred volume combination not excluded from the potential lung volume combinations for the bronchoscopic lung volume reduction, wherein the preferred volume combination targets diseased lung volumes while also targeting a preferred combined volume of the first and second lungs based on the diagnostic values from the computing step.

### Claim 52 (depends on 51)

The system of claim 51 wherein the compiling step comprises compiling a list of potential volume combinations in a ranked order.

### Claim 53 (depends on 52)

The system of claim 52 further comprising displaying the list.
